| PRKCI |
PRKCI, DXS1179E: Protein kinase C iota type |
CDC2L5 |
CDC2L5, CDC2L, CHED, KIAA1791: Cell division cycle 2-like protein kinase 5 |
13.490 |
Evidence |
|
| CSK |
CSK: Tyrosine-protein kinase CSK |
ELMO1 |
IPI00219532 |
13.490 |
Evidence |
|
| CSK |
CSK: Tyrosine-protein kinase CSK |
NEDD9 |
NEDD9, CASL: Enhancer of filamentation 1 |
13.490 |
Evidence |
|
| AKT1 |
AKT1, PKB, RAC: RAC-alpha serine/threonine-protein kinase |
STAT3 |
|
13.490 |
Evidence |
|
| AKT1 |
AKT1, PKB, RAC: RAC-alpha serine/threonine-protein kinase |
PARD6A |
PARD6A, PAR6A: Partitioning defective 6 homolog alpha |
13.490 |
Evidence |
|
| CDC25A |
CDC25A: M-phase inducer phosphatase 1 |
PKMYT1 |
PKMYT1, MYT1: Membrane-associated tyrosine- and threonine-specific cdc2-inhibito |
13.490 |
Evidence |
|
| CDC25A |
CDC25A: M-phase inducer phosphatase 1 |
PBK |
PBK, TOPK: Lymphokine-activated killer T-cell-originated protein kinase |
13.490 |
Evidence |
|
| CDC25A |
CDC25A: M-phase inducer phosphatase 1 |
PRPF4B |
PRPF4B, KIAA0536, PRP4, PRP4H, PRP4K: Serine/threonine-protein kinase PRP4 homol |
13.490 |
Evidence |
|
| CDC25A |
CDC25A: M-phase inducer phosphatase 1 |
RBL2 |
RBL2, RB2: Retinoblastoma-like protein 2 |
13.490 |
Evidence |
|
| CDC25A |
CDC25A: M-phase inducer phosphatase 1 |
CCNH |
CCNH: Cyclin-H |
13.490 |
Evidence |
|
| CDC25A |
CDC25A: M-phase inducer phosphatase 1 |
CDK7 |
CDK7, MO15: Cell division protein kinase 7 |
13.490 |
Evidence |
|
| WEE1 |
WEE1: Wee1-like protein kinase |
CDC25A |
CDC25A: M-phase inducer phosphatase 1 |
13.490 |
Evidence |
|
| TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
AKT3 |
AKT3: RAC-gamma serine/threonine-protein kinase |
13.490 |
Evidence |
|
| TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
NEDD9 |
NEDD9, CASL: Enhancer of filamentation 1 |
13.490 |
Evidence |
|
| RBL1 |
RBL1: Retinoblastoma-like protein 1 |
CDC25A |
CDC25A: M-phase inducer phosphatase 1 |
13.490 |
Evidence |
|
| MAPK1 |
MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 |
STAT3 |
|
13.490 |
Evidence |
|
| MAPK1 |
MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 |
PARD6A |
PARD6A, PAR6A: Partitioning defective 6 homolog alpha |
13.490 |
Evidence |
|
| MAPK1 |
MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 |
GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
13.490 |
Evidence |
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
PARD6A |
PARD6A, PAR6A: Partitioning defective 6 homolog alpha |
13.490 |
Evidence |
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
C10orf9 |
CCNY, C10orf9, CBCP1, CFP1: Cyclin-Y |
13.490 |
Evidence |
|
| CCNE1 |
CCNE1, CCNE: G1/S-specific cyclin-E1 |
CCNB1 |
Cyclin B1 |
13.490 |
Evidence |
|
| CCNE1 |
CCNE1, CCNE: G1/S-specific cyclin-E1 |
CDC6 |
CDC6, CDC18L: Cell division control protein 6 homolog |
13.490 |
Evidence |
|
| CCNE1 |
CCNE1, CCNE: G1/S-specific cyclin-E1 |
CDC25A |
CDC25A: M-phase inducer phosphatase 1 |
13.490 |
Evidence |
|
| CCNE1 |
CCNE1, CCNE: G1/S-specific cyclin-E1 |
MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
13.490 |
Evidence |
|
| CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
H2-ALPHA |
TUBA3C, TUBA2, TUBA3D: Tubulin alpha-3C/D chain |
13.490 |
Evidence |
|